Search

everythinglearnresearchcommunity

for

Search:↓

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

Nephronectin is linked to worse breast cancer outcomes and helps cancer spread.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

A woman developed a severe skin reaction after getting a birth control implant.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

ATP helps prevent skin damage from vandetanib by reducing stress.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

A new therapy for a skin blistering condition has not been developed yet.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

Trichorrhexis nodosa is mainly caused by hair trauma and improves with gentler hair care.

Transethosomal gels improve naftifine skin delivery better than Exoderil cream.

Large-scale fibronectin nanofibers help heal wounds and repair tissue in a skin model of a mouse.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Trichoscopy helps accurately diagnose Netherton syndrome, often mistaken for atopic dermatitis.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

The enzyme is crucial for skin cell development and can be activated without proteolytic activation.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Necl2 affects skin cell behavior and slows wound healing.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

Trichorrhexis nodosa is mainly caused by hair trauma, not a metabolic defect.

Matriptase imbalance contributes to cancer development and spread.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.